⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Beijing Yibai Technology (100doc) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Beijing Yibai Technology (100doc)
↗Beijing, China
Beijing Yibai Technology (100doc) is a prominent Chinese health-tech company founded in 2016. It provides a comprehensive SaaS-based digital marketing and data solution platform specifically designed for pharmaceutical and medical device enterprises. The company's ecosystem, known as 'Pharma MarTech,' facilitates digital academic promotion, sales management, and physician-patient management.
Their service suite includes platforms for online medical education, operational management, and intelligent data analysis. By integrating these tools, 100doc helps life science companies achieve digital transformation across the entire marketing lifecycle, serving over 1,000 pharmaceutical and medical device companies as well as 200 industry associations in China.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Healthcare Marketing SaaS
SIZE & FINANCIALS
Employees:51-200
Revenue:$10M-$50M
Founded:2016
Ownership:private
Status:operating
FUNDING
Stage:Series B
Total Raised:$2.1M+
Investors:HM Venture Partners
0
CORPORATE STRUCTURE
Key Partnerships:Chinese Medical Association (Academic cooperation), Various pharmaceutical and medical device enterprises
COMPETITION
Position:Challenger
Competitors:ACTO, IntegriChain, Multiplier AI, Softium, ForceClouds
LEADERSHIP
Key Executives:
Jianfei Gao - CEO/Founder
LINKS
Website:100doc.com.cn
Crunchbase:Crunchbase Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Beijing Yibai Technology (100doc). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.